» Articles » PMID: 23995792

The Ras-ERK Pathway Modulates Cytoskeleton Organization, Cell Motility and Lung Metastasis Signature Genes in MDA-MB-231 LM2

Overview
Journal Oncogene
Date 2013 Sep 3
PMID 23995792
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

MDA-MB-231 LM2 (herein referred to as LM2) is a derivative of MDA-MB-231 cells that was selected for its ability to metastasize to lung tissue in vivo. We investigated cellular properties of LM2 including actin cytoskeleton organization, motility and signaling pathways that drive the expression of genes associated with the lung metastasis signature. Parental cells exhibit well-developed stress fibers, whereas LM2 had poorly organized stress fibers. LM2 exhibited higher levels of K-Ras protein and corresponding higher levels of phosphorylated ERK compared with parental cells. The Ras-ERK pathway was responsible for the disruption of stress fibers because inhibition of MEK with UO126 or small interfering RNA (siRNA) against K-Ras or ERK1/2 resulted in restoration of stress fibers and focal adhesions. We observed that the K-Ras-ERK pathway is important for the expression of genes associated with the lung metastasis signature. Paradoxically, inhibition of the Ras-ERK pathway did not result in inhibition of cell motility but was accompanied by activation of the phosphatidylinositol 3-kinase (PI3K) pathway. Inhibition of both ERK and PI3K pathways was required to inhibit motility of LM2 cells. These results suggest that both ERK and PI3K pathways drive motile functions of metastatic LM2 cells and genes associated with the lung metastasis signature.

Citing Articles

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

Lai J, Liu S, Chen Y, Chen J, Li J, Liang Z MedComm (2020). 2025; 6(3):e70126.

PMID: 40066226 PMC: 11892147. DOI: 10.1002/mco2.70126.


ERK1/2 mitogen-activated protein kinase dimerization is essential for the regulation of cell motility.

de la Fuente-Vivas D, Cappitelli V, Garcia-Gomez R, Valero-Diaz S, Amato C, Rodriguez J Mol Oncol. 2024; 19(2):452-473.

PMID: 39263917 PMC: 11792999. DOI: 10.1002/1878-0261.13732.


ERK Signaling Pathway Is Constitutively Active in NT2D1 Non-Seminoma Cells and Its Inhibition Impairs Basal and HGF-Activated Cell Proliferation.

Gesualdi L, Berardini M, Scicchitano B, Castaldo C, Bizzarri M, Filippini A Biomedicines. 2023; 11(7).

PMID: 37509533 PMC: 10377482. DOI: 10.3390/biomedicines11071894.


Oncogenic Ras deregulates cell-substrate interactions during mitotic rounding and respreading to alter cell division orientation.

Ganguli S, Wyatt T, Nyga A, Lawson R, Meyer T, Baum B Curr Biol. 2023; 33(13):2728-2741.e3.

PMID: 37343559 PMC: 7614879. DOI: 10.1016/j.cub.2023.05.061.


TMEM176B Regulates AKT/mTOR Signaling and Tumor Growth in Triple-Negative Breast Cancer.

Kang C, Rostoker R, Ben-Shumel S, Rashed R, Duty J, Demircioglu D Cells. 2021; 10(12).

PMID: 34943938 PMC: 8700203. DOI: 10.3390/cells10123430.